補體因子I(CFI)多克隆抗體
Polyclonal Antibody to Complement Factor I (CFI)
CF-I; C3b-INA; FI; IF; KAF; Factor I; Konglutinogen-Activating Factor; C3b-Inactivator; C3B/C4B inactivator
- 編號PAB978Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPB978Hu01-補體因子I(CFI)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術,請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 598 ¥ 1394 ¥ 1992 ¥ 4980 ¥ 19920
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
特異性
該抗體是針對CFI的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別CFI。
用法
Western blotting: 0.5-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當?shù)臈l件下存儲,損失率低于5%。
贈品
增值服務
相關產品
編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) |
RPB978Hu02 | 補體因子I(CFI)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB978Hu01 | 補體因子I(CFI)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB978Hu01 | 補體因子I(CFI)多克隆抗體 | WB; IHC; ICC; IP. |
PAB978Hu02 | 補體因子I(CFI)多克隆抗體 | WB; IHC; ICC; IP. |
MAB978Hu22 | 補體因子I(CFI)單克隆抗體 | WB; IHC; ICC; IP. |
WEB978Hu | 補體因子I(CFI)檢測試劑盒(酶聯(lián)免疫吸附試驗法,寬范圍) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SEB978Hu | 補體因子I(CFI)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB978Hu | 補體因子I(CFI)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
J Thromb Haemost | A case report of thrombotic microangiopathy without renal involvement carrying two novel mutations in complement-regulator genes [PubMed: 26613809] |
Pediatr Int | Atypical hemolytic uremic syndrome: Korean pediatric series [PubMed: 25443527] |
United States Patent Application? | NOVEL ASSAY [y2016:139118] |
Researchgate | Compliment factor i bioassay [US20170285024] |
PLoS One | A monoclonal antibody targeting amyloid β (Aβ) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and?… [Pubmed:29782502] |
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | The importance of sialic acid, pH and ion concentration on the interaction of uromodulin and complement factor H [33788378] |
留言咨詢